Intention-to-treat analysis | T1 | T2 | T3 |
---|---|---|---|
baseline | post intervention | follow-up | |
Strategy SAS†| 21.8% (37 wards) | 40.4% (37 wards) | 45.9% (37 wards) |
Δ T1-T2 18.6% | Δ T1-T3 24.1% | ||
Strategy TDS‡ | 19.1% (30 wards) | 53.1% (30 wards) | 52.1% (30 wards) |
Δ T1-T2 34.0% | Δ T1-T3 33.0% | ||
Groups compared | Â | Â | Â |
TDS vs. SAS | f=0.465 | f=19.409 | f=1.781 |
ANOVA | p=0.498 | p=0.000** | p=0.187* |
As-received analysis | T1 | T2 | T3 |
baseline | post intervention | follow-up | |
Strategy SAS†| 21.5% (47 wards) | 40.7% (47 wards) | 44.1% (47 wards) |
Δ T1-T2 19.2% | Δ T1-T3 22.6% | ||
Strategy TDS‡ | 20.7% (20 wards) | 58.6% (20 wards) | 59.5% (20 wards) |
Δ T1-T2 37.9% | Δ T1-T3 38.8% | ||
Groups compared | Â | Â | Â |
TDS vs. SAS | f=0.001 | f=40.304 | f=10.187 |
ANOVA | p=0.978 | p=0.000** | p=0.002** |
Groups compared | Â | Â | Â |
SAS groups randomised to TDS (n=10) vs SAS groups randomised to SAS (n= 37) | p=0.322 | p=0.650 | p=0.224 |
T-test | Â | Â | Â |